|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 130.21 USD | -0.82% |
|
+0.70% | +6.09% |
| 30/07 | Merck, Wellcome partner with global health group to make Ebola vaccine for clinical trials | RE |
| 28/07 | Atea Pharmaceuticals Says Combination Drug Meets Endpoints in Phase 3 Hepatitis C Trial | MT |
Quotes 5-day view: Gilead Sciences, Inc.
Delayed Quote Nasdaq
| 27/07/2026 | 28/07/2026 | 29/07/2026 | 30/07/2026 | 31/07/2026 | |
|---|---|---|---|---|---|
| Last | USD 130.52 | USD 134.32 | USD 132.73 | USD 131.28 | USD 130.21 |
| Volume | 4,953,801 | 6,947,167 | 7,766,370 | 6,726,143 | 6,531,645 |
| Change | +0.94% | +2.91% | -1.18% | -1.09% | -0.82% |
| Opening | USD 131.00 | USD 133.11 | USD 134.41 | USD 130.02 | USD 130.23 |
| High | USD 133.06 | USD 136.26 | USD 134.64 | USD 131.39 | USD 130.89 |
| Low | USD 129.43 | USD 132.63 | USD 132.57 | USD 128.28 | USD 128.76 |
Performance
| 1 day | -0.82% | ||
| 1 week | +0.70% | ||
| 1 month | -0.81% | ||
| 3 months | -1.09% | ||
| 6 months | -8.87% | ||
| Current year | +6.09% | ||
| 1 year | +15.05% | ||
| 3 years | +72.05% | ||
| 5 years | +90.50% | ||
| 10 years | +63.64% |
Volumes
marketsDaily volume
6,531,645
Estimated daily volume
6,531,645
Avg. Volume 20 sessions
6,111,484
Daily volume ratio
1.07
Avg. Volume 20 sessions USD
795,776,331.64
Record volume 1
455,344,000
Record volume 2
267,611,064
Record volume 3
264,222,464
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
161,664,813,293
Net sales (USD)
29,443,000,000
Number of employees
17,000
Sales / Employee (USD)
1,731,941
Free-Float
99.88 %
Free-Float capitalization (USD)
161,468,270,543
Average Daily Capital Traded
0.49%
Indicators
Moving average 5 days
131.81
Moving average 20 days
132.22
Moving average 50 days
129.74
Moving average 100 days
133.24
Price spread / (MMA5)
+1.23%
Price spread / (MMA20)
+1.54%
Price spread / (MMA50)
-0.36%
Price spread / (MMA100)
+2.33%
STIM
RSI 9 days
49.52
RSI 14 days
50.57
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.82% | +0.70% | +15.05% | +72.05% | 162B | |
| -0.53% | -3.95% | +50.70% | +152.78% | 1,024B | |
| +0.21% | -2.68% | +53.20% | +50.87% | 618B | |
| -2.51% | -3.25% | +28.54% | +67.99% | 443B | |
| +0.06% | -0.42% | +37.53% | +31.06% | 349B | |
| -0.14% | -0.24% | +34.41% | +39.49% | 297B | |
| -0.69% | -0.30% | +13.76% | +13.84% | 264B | |
| -7.37% | -4.40% | -0.74% | -43.66% | 209B | |
| -0.64% | +2.43% | +29.74% | +67.16% | 208B | |
| +0.40% | +1.92% | +6.47% | -29.25% | 143B | |
| Average | -1.20% | -1.02% | +26.87% | +42.23% | 371.63B | |
| Weighted average by Cap. | -0.94% | -2.01% | +36.00% | +69.06% |
Historical Quotes: Gilead Sciences, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
5e3df1.RWk7YfSaNp4NeKms7zRwkWeYuics-veM-3TC-Sb5jnQ.CS5cIpfdBKxVG8LVmllI8CPKwmR5o4DPqge2rU7P1zwqWg0RkdlczyA76A
| Date | Price | Volume | Total |
|---|---|---|---|
| 06:00:00 am | 130.21 | 1,369,361 | 4,398,801 |
| 05:59:59 am | 130.21 | 1,029 | 3,029,440 |
| 05:59:59 am | 130.21 | 271 | 3,028,411 |
| 05:59:59 am | 130.26 | 200 | 3,028,140 |
| 05:59:59 am | 130.26 | 100 | 3,027,940 |
| 05:59:59 am | 130.24 | 100 | 3,027,840 |
| 05:59:59 am | 130.21 | 1,972 | 3,027,740 |
| 05:59:59 am | 130.21 | 201 | 3,025,768 |
| 05:59:59 am | 130.24 | 600 | 3,025,567 |
| 05:59:59 am | 130.24 | 471 | 3,024,967 |
Course Extremes
| 1 week | 128.28 |  | 136.26 |
| 1 month | 127.61 | | 140.61 |
| Current year | 116.88 | | 157.29 |
| 1 year | 108.46 | | 157.29 |
| 3 years | 62.07 | | 157.29 |
| 5 years | 57.16 | | 157.29 |
| 10 years | 56.56 | | 157.29 |
Monthly variations
Annual variations
| 2026 | +6.09% | ||
| 2025 | +32.88% | ||
| 2024 | +14.02% | ||
| 2023 | -5.64% | ||
| 2022 | +18.23% | ||
| 2021 | +24.63% | ||
| 2020 | -10.34% | ||
| 2019 | +3.88% | ||
| 2018 | -12.69% | ||
| 2017 | +0.04% | ||
| 2016 | -29.23% | ||
| 2015 | +7.35% | ||
| 2014 | +25.51% | ||
| 2013 | +104.49% | ||
| 2012 | +79.45% | ||
| 2011 | +12.94% | ||
| 2010 | -16.25% | ||
| 2009 | -15.39% | ||
| 2008 | +11.15% | ||
| 2007 | +41.72% | ||
| 2006 | +23.51% | ||
| 2005 | +50.24% | ||
| 2004 | +20.08% | ||
| 2003 | +71.41% | ||
| 2002 | +3.47% | ||
| 2001 | +58.48% | ||
| 2000 | +53.23% | ||
| 1999 | +31.81% | ||
| 1998 | +7.35% | ||
| 1997 | +53.00% | ||
| 1996 | -21.88% | ||
| 1995 | +236.84% | ||
| 1994 | -20.83% | ||
| 1993 | -37.66% | ||
| 1992 | -4.94% |
- Stock Market
- Stocks
- GILD Stock
- Quotes Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
